One pill, once daily
Find out about starting OJJAARA.

You are about to leave a GSK website
You are about to leave a GSK website. By clicking this link, you will be taken to a website that is independent from GSK. The site you are linking to is not controlled or endorsed by GSK and GSK is not responsible for its content.
OJJAARA is the first and only FDA-approved prescription medicine used specifically to treat adults with certain types of myelofibrosis who have anemia. It is not known if OJJAARA is safe and effective in children.
Find out about starting OJJAARA.
Together with GSK Oncology can help you with access and reimbursement services for OJJAARA.
Find information and resources for people who are caring for a loved one with myelofibrosis with anemia.
OJJAARA has helpful downloadable resources for people living with myelofibrosis with anemia and their caregivers.
Sign up to receive more information about myelofibrosis with anemia and OJJAARA.